MeSH tree: D03.633.100
A single dose of psilocybin, the active compound in magic mushrooms, reduces nerve pain for up to a month and makes a widely used painkiller work more effectively, University of Reading research has found.
May 22, 2026
0
35
A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found.
May 22, 2026
0
10
As more people look for ways to stay younger for longer, the supplement industry has moved beyond creams and cosmetic fixes to something more ambitious: products that claim to slow aging by acting on cellular processes.
May 20, 2026
0
15
Lighting accounts for almost 8% of the world's energy usage. It makes up around 10–20% of domestic energy bills, with an even higher proportion in commercial premises like offices.
May 20, 2026
0
5
Using psychoactive substances for recreation, socialization or symptom self-management is common for many people living with multiple sclerosis. When used to self-manage symptoms, some psychoactive substances may provide ...
May 19, 2026
0
6
Researchers from the University of California San Diego found that prescriptions for leucovorin, a drug sometimes used off-label for autism spectrum disorder (ASD), rose sharply among children after widespread media attention ...
May 18, 2026
0
9
Severe childhood malaria is linked to long-term cognitive impairment, according to a new study from Indiana University School of Medicine researchers and their collaborators at Makerere University in Uganda. The findings, ...
May 16, 2026
0
6
A single dose of the psychedelic substance psilocybin can provide rapid relief from depressive symptoms—within just a few days. This is shown by the first randomized, double-blind study in Sweden of psilocybin for depression. ...
May 15, 2026
0
73
A nationwide study from Denmark presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use of semaglutide (Wegovy) for weight management is associated with a 7% reduction in the use of triptan-class ...
May 15, 2026
0
6
Since his second term started, President Donald Trump has announced, negotiated or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry.
May 12, 2026
0
6
